Top Markets
Coin of the day
CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGX
Classement en actions #18093
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company... CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.
Prix de l'action
$4.47
Dernière synchronisation: 2025-08-20
Capitalisation boursière
$213.06M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange CARGO Therapeutics, Inc. Common Stock (CRGX)

Catégorie

Ratio P/B pour CARGO Therapeutics, Inc. Common Stock (CRGX)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de CARGO Therapeutics, Inc. Common Stock, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour CARGO Therapeutics, Inc. Common Stock de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
6.828 -
US
7.5116 -
NL
8.2199 -
US
3.9942 -
AU
- -
CH